精神分裂症中的性功能障碍:系统综述与Meta分析
最常见的障碍为男性勃起功能障碍(44%),其次为男性性欲丧失(41%)、男性射精功能障碍(39%)、女性性高潮障碍(28%)和女性闭经(25%)。抗抑郁药使用与较低的勃起和射精障碍率相关。
要点
- 精神分裂症患者性功能障碍总患病率为56.4%,男性55.7%,女性60.0%。
- 男性最常见为勃起功能障碍(44%),女性为性高潮障碍(28%)和闭经(25%)。
- 抗抑郁药和心境稳定剂处方与较低的勃起及射精障碍率相关。
核心结论
- 精神分裂症患者中性功能障碍患病率高,相关因素异质性大,部分障碍可能由疾病本身解释,治疗共病抑郁或可改善性健康。
主要发现
- 性功能障碍总患病率56.4%(95%CI 50.5-62.2),男性55.7%(95%CI 48.1-63.1),女性60.0%(95%CI 48.0-70.8)。
- 男性最常见为勃起功能障碍44%(95%CI 33.5-55.2),其次性欲丧失41%(95%CI 30.7-51.4)、射精功能障碍39%(95%CI 26.8-51.8)。
- 女性最常见为性高潮障碍28%(95%CI 18.4-40.2)和闭经25%(95%CI 17.3-35.0)。
- 精神分裂症比分裂情感性障碍性功能障碍更频繁,病程更长者勃起障碍较少。
临床怎么用
- 临床应常规关注精神分裂症患者的性功能障碍,尤其是男性勃起功能障碍和女性性高潮障碍及闭经。
- 评估性功能障碍时需考虑合并抑郁并合理使用抗抑郁药,可能有助于改善性健康。
局限性
- 研究间异质性大,与设计、时间地点、社会人口学、酒精使用障碍、精神科诊断、疾病严重度及药物使用相关。
- 缺乏代谢参数和躯体健康数据,抗精神病药类别与性功能障碍关系结果不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In individuals with schizophrenia, antipsychotic-induced dysfunctions are frequent but often underexplored in clinical practice. OBJECTIVE: To synthetize the data of observational studies exploring the prevalence of sexual dysfunction in individuals with schizophrenia-spectrum disorders as well as associated factors. DATA SOURCES: A systematic literature search without language or time restrictions was conducted in Google, Google Scholar, PubMed/MEDLINE, Science Direct, and Université Sorbonne Paris Cité for studies published up to June 8, 2022. STUDY SELECTION: All observational studies reporting a prevalence of sexual dysfunction in schizophrenia-spectrum disorder were included. DATA EXTRACTION AND SYNTHESIS: The MOOSE guidelines with independent extraction by 2 observers and random-effects models were used. MAIN OUTCOMES AND MEASURES: The prevalence of sexual dysfunction and each specific dysfunction. RESULTS: A total of 72 of 1119 studies from 33 countries on 6 continents published from inception to June 2022 were included with a total of 21 076 participants with schizophrenia. The pooled global prevalence of sexual dysfunctions was 56.4% (95% CI, 50.5-62.2), with a prevalence of 55.7% (95% CI, 48.1-63.1) for men and 60.0% (95% CI, 48.0-70.8) for women. The most frequent sexual dysfunction was erectile dysfunction in men (44%; 95% CI, 33.5-55.2), followed by loss of libido in men (41%; 95% CI, 30.7-51.4), ejaculation dysfunction in men (39%; 95% CI, 26.8-51.8), orgasm dysfunction in women (28%; 95% CI, 18.4-40.2), and amenorrhea in women (25%; 95% CI, 17.3-35.0). Factors associated with heterogeneity were study design, time and location, sociodemographic data, alcohol use disorder, psychiatric diagnosis, illness severity, and the use of antidepressants and anxiolytics. Sexual dysfunctions were more frequent in schizophrenia vs schizoaffective disorders, and erectile disorders were less frequent in individuals with longer illness duration. Antidepressant and mood stabilizer prescriptions were associated with lower rates of erection disorders (β, -6.30; 95% CI, -10.82 to -1.78); P = .006 and -13.21; 95% CI, -17.59 to -8.83; P < .001, respectively) and ejaculation disorders (β, -6.10; 95% CI, -10.68 to -1.53; P = .009 and β, -11.57; 95% CI, -16.34 to -6.80; P < .001, respectively). No obvious improvements in the rates of sexual dysfunction at other times were found, and there were conflicting results regarding antipsychotic classes. CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found a high prevalence of sexual dysfunction among individuals with schizophrenia, with considerable heterogeneity in associated factors. The findings also suggest that some dysfunctions may be explained by schizophrenia. The association between lower rates of dysfunction and antidepressant use suggests that treating comorbid depression could be an effective strategy to improve sexual health. A lack of data on metabolic parameters and physical health in general was also noted, while these issues are frequent in the care of schizophrenia.
引用
- Korchia T, Achour V, Faugere M, et al. Sexual Dysfunction in Schizophrenia: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2023. PMID: 37703012. doi:10.1001/jamapsychiatry.2023.2696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。